Fundraising Fox

Ark Biosciences

Shanghai, CN · 2 known investors

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

BiotechDigital HealthHealthtechMedical Devices

Investors · 2

Decheng CapitalMenlo Park
Qiming Venture PartnersreportedBeijing · $5M – $134M

In the news

Chinese Biotech Startup Ark Biosciences Closes Series A Extension Led By Bioventure Investmentnews.marketersmedia.com · Feb 2017Shanghai's Ark Biosciences Closes A+ Funding For Anti-Virals - BioSpacebiospace.com · Feb 2017Ark Biosciences Of Shanghai Completes Series A Funding - BioSpacebiospace.com · Apr 2015

Frequently asked questions

What does Ark Biosciences do?
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.
Who are Ark Biosciences's investors?
Ark Biosciences's investors include Decheng Capital, Qiming Venture Partners.
Where is Ark Biosciences headquartered?
Ark Biosciences is headquartered in Shanghai, CN.